G
Name | Dosage form | ATC code |
---|---|---|
Chinofucin Chinofucin 0,015 g № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,015 g № 5, № 10 | G01AC03 |
Eucolec Eucolec 0,05 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,05 g № 5, № 10 | G01AX |
Klioron Klioron 16 mg № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
16 mg № 10 | G01AX |
Klioron V Klioron V 16 mg № 10 Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
16 mg № 10 | G01AX |
Lekfucin Lekfucin 15 mg № 5, № 10 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
15 mg № 5, № 10 | G01AС03 |
Leknazole Leknazole 150 mg № 3 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
150 mg № 3 | G01АF05 |
Lekvolek Lekvolek 50 mg № 5, № 10 Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 5, № 10 | G01AX |
Levoklek Levoklek 50 mg № 5, № 10 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 5, № 10 | G01AX |
Omix Omix 0,4 mg № 10, № 30 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,4 mg № 10, № 30 | G04CA02 |
Omix Omix 0.4 mg № 10, № 30 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0.4 mg № 10, № 30 | G04C A02 |
Potentiale Potentiale 100 mg № 1 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg № 1 | G04BE03 |
Potentiale Potentiale 50 mg № 1 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 1 | G04BE03 |
Potentiale Potentiale 50 mg № 2 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 2 | G04BE03 |
Potentiale Potentiale 50 mg №4 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg №4 | G04BE03 |
Potentiale Potentiale 100 mg №2 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg №2 | G04BE03 |
Potentiale Potentiale 100 mg №4 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg №4 | G04BE03 |
Povidin Povidin 0,3 g № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,3 g № 5, № 10 | G01AX11 |
Prostan Prostan 5 mg № 10, № 30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
5 mg № 10, № 30 | G04CB01 |
Prostatilen Prostatilen 2 ml № 5, № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
2 ml № 5, № 10 | G04СX |
Prostatilen Prostatilen 0,03 g №5 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,03 g №5 | G04CX |
Prostatilen Prostatilen 0,03 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,03 g № 10 | G04CX |
Prostatilen-Zinc Prostatilen-Zinc №10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
№10 | G04CX |
Prostatilen-Zinc Prostatilen-Zinc № 5 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
№ 5 | G04CX |
Santekvin Santekvin 0,15 g № 3 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,15 g № 3 | G01AF05 |